Articles from Cirtec Medical

BROOKLYN PARK, Minn., Sept. 16, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical is pleased to announce that Chris Cleary has been appointed to its Board of Directors. Chris brings over thirty years of experience in corporate development, mergers and acquisitions, and venture and structured investments in the medical device and healthcare technology sectors. Chris currently serves as Chief Executive Officer of Biomergence Capital, a position he assumed in March 2024. Prior to this role, he led global acquisition and investment strategy at Medtronic, where he was instrumental in executing more than 35 acquisitions and numerous venture and structured investments. Notably, he played a central role in Medtronic’s $50 billion acquisition of Covidien in 2014 and later managed the $6 billion divestiture of Covidien’s medical supply assets to Cardinal Health.

BROOKLYN PARK, Minn., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Cirtec Medical, a leading strategic outsourcing partner for complex minimally invasive, active implantable devices and precision components, is pleased to announce the appointment of Shar Matin as Chief Executive Officer, effective September 2, 2025.

Cirtec Medical, a leading outsource partner for end-to-end medical device design, development and manufacturing services, is more than doubling its operations in Costa Rica. This strategic expansion is designed to better serve Cirtec's customers by offering enhanced manufacturing capabilities and increased capacity to support their growing needs in the neuromodulation, interventional, electrophysiology and structural heart markets.